Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00656_DB00705_nanopub.RAvgWENd_B1ZvfotGS3duJwkd2R9ALZjgOr2wo-eHBvfs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00656_DB00705 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00656_DB00705 label "DDI between Trazodone and Delavirdine - The CYP3A4 inhibitor, Delavirdine, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Delavirdine is initiated, discontinued or dose changed. [drugbank_resource:DB00656_DB00705]" assertion.
- drugbank_resource:DB00656_DB00705 identifier "drugbank_resource:DB00656_DB00705" assertion.
- drugbank_resource:DB00656_DB00705 title "DDI between Trazodone and Delavirdine - The CYP3A4 inhibitor, Delavirdine, may increase Trazodone efficacy/toxicity by decreasing Trazodone metabolism and clearance. Consider alternate therapy or monitor for changes in Trazodone efficacy/toxicity if Delavirdine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00656 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00705 assertion.
- drugbank:DB00705 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00656_DB00705 assertion.